The 2nd most downloaded article in #50YearsofDrugs is a systematic literature review of the clinical outcomes of switching reference medicines to biosimilars. The results? No change. https://t.co/pyqhxNJuCH
RT @DrugsJournal: In the last #50YearsofDrugs, this article was shared widely after publication. Switching Reference Medicines to #Biosimil…
In the last #50YearsofDrugs, this article was shared widely after publication. Switching Reference Medicines to #Biosimilars: a systematic review of clinical outcomes by Hillel Cohen and a global group of collaborators https://t.co/dow68kUGPa
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇
RT @KristinRaworth: Day in and day out @shandro responds at length and respectfully on twitter to questions about health policy. He is usi…
RT @KristinRaworth: Day in and day out @shandro responds at length and respectfully on twitter to questions about health policy. He is usi…
RT @KristinRaworth: Day in and day out @shandro responds at length and respectfully on twitter to questions about health policy. He is usi…
RT @KristinRaworth: Day in and day out @shandro responds at length and respectfully on twitter to questions about health policy. He is usi…
RT @KristinRaworth: Day in and day out @shandro responds at length and respectfully on twitter to questions about health policy. He is usi…
RT @KristinRaworth: Day in and day out @shandro responds at length and respectfully on twitter to questions about health policy. He is usi…
RT @KristinRaworth: Day in and day out @shandro responds at length and respectfully on twitter to questions about health policy. He is usi…
RT @KristinRaworth: Day in and day out @shandro responds at length and respectfully on twitter to questions about health policy. He is usi…
@loveandsalty There is ten years of data of switching in Europe. It is now unknown. And the myth that one can’t switch back is not supported by the data either. https://t.co/pFcXzmKJU2
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇 https://t.co/knJ…
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇 https://t.co/knJ…
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇 https://t.co/knJ…
RT @shandro: There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇
There's actually 90 published studies. This paper from 2018 summarizes them: https://t.co/UmHsJkKyFb More 👇
RT @BioSim_es: Muy relevante este estudio sobre intercambiabilidad de medicamentos biológicos. Meta-análisis de 90 estudios con 14.225 paci…
@SaleemRazack @picardonhealth @kellygrant1 @globeandmail Thus far, the literature seems to not show any significant difference between the originator and biosimilar to date. Here is a nice systematic review from 2018 on this question https://t.co/HIcoZhUQQ
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes. https://t.co/dtFymFVpUA
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes @diariofarma https://t.co/Uy8iUYN0Nk
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
The results suggest a low risk of either a safety concern or a loss of efficacy after switching to a biosimilar
RT @GarciaLourdes15: Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes https://t.co/IjeRnY…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes https://t.co/IjeRnYvxAF
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @PatLacruz: 👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference me…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
👁 Revisión sistemática: Switching Reference Medicines to Biosimilars. Conclusiones:The act of switching from a reference medicine to a biosimilar is not inherently dangerous, and that patients, healthcare professionals, and the public should not assume th
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
RT @sefh_: #SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clín…
#SystematicReview Switch de medicamentos de referencia a #biosimilares: revisión sistemática de la literatura de resultados clínicos https://t.co/kZ3AS0IwmM https://t.co/ppuIzXcL5j
@DanielleMedek @Cheshil Anti-drug antibody (ADA) assays likely offer the most sensitive method to detect drug immunogenicity; and neutralizing antibodies (NAB) assays are the most direct method to signal the potential clinical relevance of ADAs [Cohen et a
RT @BrianLehman1: Author to discuss systematic literature review of switching studies, July 12, 2pm ET https://t.co/QS2aF9gWDJ #biosimilars…
Author to discuss systematic literature review of switching studies, July 12, 2pm ET https://t.co/QS2aF9gWDJ #biosimilars https://t.co/6NCjndEFsj
RT @medicinesforEU: Systematic literature review on switching from reference to #biosimilars provides data to negate theoretical concerns h…
Systematic literature review on switching from reference to #biosimilars provides data to negate theoretical concerns https://t.co/cjDkSA8bTy #BiosimilarsGoGlobal #AskaboutBiosimilars #BiologicsForAll - you can find out more about this key topic at #BIOS18
Systematic literature review on switching from reference to biosimilar medicines confirms the positive findings of European regulators https://t.co/cjDkSzQB20 #BiosimilarsGoGlobal #AskaboutBiosimilars #BiologicsForAll https://t.co/wj2bVvOkDQ
Evidence continues to pour in, but the communication and regulatory challenges remain. Access to #biosimilars and #biologics is not just a question of #data . https://t.co/zXa5Se28qg
La raccolta di dati su oltre 14.000 individui da 90 diversi studi clinici rassicura sul rischio di maggiore immunogenicità o di perdita di efficacia quando si passa da farmaco originale a biosimilare https://t.co/KWIFib92QA
Switching to biosimilar medicines: have you seen the conclusion of this systematic literature review? https://t.co/cjDkSzQB20 #BiosimilarsGoGlobal #AskaboutBiosimilars #BiologicsForAll https://t.co/6fvNHPReJl
RT @sefh_: Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes. PDF: https://t.co/0CyONGtbeK
Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes. PDF: https://t.co/0CyONGtbeK
RT @BiosimsCouncil: The most extensive literature review available supports confidence in switching from reference to #biosimilar medicines…
RT @BiosimsCouncil: The most extensive literature review available supports confidence in switching from reference to #biosimilar medicines…